当前位置: X-MOL 学术Lancet Haematol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Fine-tuning the risk assessment and treatment of patients with intermediate-risk pulmonary embolism.
The Lancet Haematology ( IF 15.4 ) Pub Date : 2021-08-04 , DOI: 10.1016/s2352-3026(21)00235-0
Helia Robert-Ebadi 1
Affiliation  



中文翻译:

微调中危肺栓塞患者的风险评估和治疗。

更新日期:2021-08-04
down
wechat
bug